Inj, panzyga, 500 mg
Products billed under this code include Panzyga.
Payment limit per 500 MG, by effective quarter, 3Q23 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.Products billed under J1576
From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Panzyga | Pfizer Inc | 00069-1109-02 | 5 | $351.25 |
| Panzyga | Pfizer Inc | 00069-1224-02 | 10 | $702.50 |
| Panzyga | Pfizer Inc | 00069-1312-02 | 20 | $1,405.00 |
| Panzyga | Pfizer Inc | 00069-1415-02 | 40 | $2,810.00 |
| Panzyga | Pfizer Inc | 00069-1558-02 | 60 | $4,215.00 |
| Panzyga | Octapharma USA Inc. | 68982-0822-02 | 5 | $351.25 |
| Panzyga | Octapharma USA Inc. | 68982-0822-03 | 10 | $702.50 |
| Panzyga | Octapharma USA Inc. | 68982-0822-04 | 20 | $1,405.00 |
| Panzyga | Octapharma USA Inc. | 68982-0822-05 | 40 | $2,810.00 |
| Panzyga | Octapharma USA Inc. | 68982-0822-06 | 60 | $4,215.00 |
Every quarter
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $70.25 | −$1.096 | 500 MG | Inj, panzyga, 500 mg | v1, posted September 17, 2026 |
| 3Q26 | $71.346 | −$2.484 | 500 MG | Inj, panzyga, 500 mg | v1, posted September 15, 2026 |
| 2Q26 | $73.83 | +$2.607 | 500 MG | Inj, panzyga, 500 mg | v1, posted September 15, 2026 |
| 1Q26 | $71.223 | −$1.773 | 500 MG | Inj, panzyga, 500 mg | v1, posted September 15, 2026 |
| 4Q25 | $72.996 | −$1.461 | 500 MG | Inj, panzyga, 500 mg | v1, posted September 8, 2026 |
| 3Q25 | $74.457 | +$4.025 | 500 MG | Inj, panzyga, 500 mg | v1, posted March 10, 2026 |
| 2Q25 | $70.432 | +$1.334 | 500 MG | Inj, panzyga, 500 mg | v1, posted March 10, 2026 |
| 1Q25 | $69.098 | +$1.637 | 500 MG | Inj, panzyga, 500 mg | v1, posted December 19, 2025 |
| 4Q24 | $67.461 | −$2.304 | 500 MG | Inj, panzyga, 500 mg | v1, posted June 11, 2025 |
| 3Q24 | $69.765 | +$4.816 | 500 MG | Inj, panzyga, 500 mg | v1, posted June 11, 2025 |
| 2Q24 | $64.949 | −$1.492 | 500 MG | Inj, panzyga, 500 mg | v1, posted March 11, 2025 |
| 1Q24 | $66.441 | +$0.737 | 500 MG | Inj, panzyga, 500 mg | v1, posted December 19, 2024 |
| 4Q23 | $65.704 | −$0.037 | 500 MG | Inj, panzyga, 500 mg | v1, posted October 10, 2024 |
| 3Q23 | $65.741 | – | 500 MG | Inj, panzyga, 500 mg | v1, posted June 5, 2024 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.
CMS source files
- 4Q26: 2026-09-17_october-2026-medicare-part-b-payment-limit-files-final.zipposted September 17, 2026
- 4Q26: 2026-09-17_october-2026-ndc-hcpcs-crosswalk-final.zipposted September 17, 2026
- 3Q26: 2026-09-15_july-2026-medicare-part-b-payment-limit-files.zipposted September 15, 2026
- 2Q26: 2026-09-15_april-2026-medicare-part-b-payment-limit-files-final-file.zipposted September 15, 2026
- 1Q26: 2026-09-15_january-2026-medicare-part-b-payment-limit-files.zipposted September 15, 2026
- 4Q25: 2026-09-08_october-2025-asp-pricing-final-file.zipposted September 8, 2026
- 3Q25: 2026-03-10_july-2025-asp-pricing-file.zipposted March 10, 2026
- 2Q25: 2026-03-10_april-2025-asp-pricing-file.zipposted March 10, 2026
- 1Q25: 2025-12-19_january-2025-asp-pricing-file-03-11-25-final-file.zipposted December 19, 2025
- 4Q24: 2025-06-11_october-2024-asp-pricing-file.zipposted June 11, 2025
- 3Q24: 2025-06-11_july-2024-asp-pricing-file.zipposted June 11, 2025
- 2Q24: 2025-03-11_april-2024-asp-pricing-file.zipposted March 11, 2025
- 1Q24: 2024-12-19_january-2024-asp-pricing-file.zipposted December 19, 2024
- 4Q23: 2024-10-10_october-2023-asp-pricing-file.zipposted October 10, 2024
- 3Q23: 2024-06-05_july-2023-asp-pricing-file.zipposted June 5, 2024